Nagai A - Search Results

1

Effects of purified newly developed botulinum neurotoxin type A in rat prostate.

Nishiyama Y, Yokoyama T, Tomizawa K, Okamura K, Yamamoto Y, Matsui H, Oguma K, Nagai A, Kumon H. Nishiyama Y, et al. Among authors: nagai a. Urology. 2009 Aug;74(2):436-9. doi: 10.1016/j.urology.2009.01.047. Epub 2009 Apr 15. Urology. 2009. PMID: 19371936

2

Botulinum toxin type A for the treatment of lower urinary tract disorders.

Yokoyama T, Chancellor MB, Oguma K, Yamamoto Y, Suzuki T, Kumon H, Nagai A. Yokoyama T, et al. Among authors: nagai a. Int J Urol. 2012 Mar;19(3):202-15. doi: 10.1111/j.1442-2042.2011.02946.x. Epub 2012 Jan 6. Int J Urol. 2012. PMID: 22220916 Review.

3

Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxin.

Yokoyama T, Yamamoto Y, Suzuki T, Oguma K, Nagai A. Yokoyama T, et al. Among authors: nagai a. Acta Med Okayama. 2012;66(4):291-7. doi: 10.18926/AMO/48668. Acta Med Okayama. 2012. PMID: 22918201 Free article. Clinical Trial.

4

Laparoscopic removal of Müllerian structures and orchiopexy for persistent Müllerian duct syndrome.

Shirasaki Y, Nagai A, Nasu Y, Iguchi H, Kumon H. Shirasaki Y, et al. Among authors: nagai a. Urology. 2003 Dec;62(6):1121. doi: 10.1016/j.urology.2003.07.005. Urology. 2003. PMID: 14665371

5

High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatments.

Yokoyama T, Tsugawa M, Nagai A, Kumon H. Yokoyama T, et al. Among authors: nagai a. Acta Med Okayama. 2004 Jun;58(3):151-6. doi: 10.18926/AMO/32106. Acta Med Okayama. 2004. PMID: 15471437 Free article.

6

Analysis of human ejaculation using color Doppler ultrasonography: a comparison between antegrade and retrograde ejaculation.

Nagai A, Watanabe M, Nasu Y, Iguchi H, Kusumi N, Kumon H. Nagai A, et al. Urology. 2005 Feb;65(2):365-8. doi: 10.1016/j.urology.2004.09.016. Urology. 2005. PMID: 15708054

7

Varicocele rupture due to sexual intercourse.

Nishiyama Y, Nagai A, Nasu Y, Watanabe M, Kusumi N, Monden K, Kumon H. Nishiyama Y, et al. Among authors: nagai a. Int J Urol. 2005 Jun;12(6):585-7. doi: 10.1111/j.1442-2042.2005.01096.x. Int J Urol. 2005. PMID: 15985084

8

Natural course of lower urinary tract symptoms following discontinuation of alpha-1-adrenergic blockers in patients with benign prostatic hyperplasia.

Yokoyama T, Watanabe T, Saika T, Nasu Y, Kumon H, Miyaji Y, Nagai A. Yokoyama T, et al. Among authors: nagai a. Int J Urol. 2007 Jul;14(7):598-601. doi: 10.1111/j.1442-2042.2007.01784.x. Int J Urol. 2007. PMID: 17645601

9

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.

Yokoyama T, Uematsu K, Watanabe T, Sasaki K, Kumon H, Nagai A; Okayama Urological Research Group. Yokoyama T, et al. Among authors: nagai a. Scand J Urol Nephrol. 2009;43(4):307-14. doi: 10.1080/00365590902836740. Scand J Urol Nephrol. 2009. PMID: 19396723 Clinical Trial.

10

Application of purified botulinum type a neurotoxin to treat experimental trigeminal neuropathy in rats and patients with urinary incontinence and prostatic hyperplasia.

Matsuka Y, Yokoyama T, Yamamoto Y, Suzuki T, Dwi Fatmawati NN, Nishikawa A, Ohyama T, Watanabe T, Kuboki T, Nagai A, Oguma K. Matsuka Y, et al. Among authors: nagai a. J Toxicol. 2012;2012:648384. doi: 10.1155/2012/648384. Epub 2012 Jun 14. J Toxicol. 2012. PMID: 22745637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,033 results

Search Page

Filters